Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
SafeGuard Ventures is a private consumer health company focused on sexual wellness products rather than drug development. Publicly available information indicates the company develops and markets patented, all-in-one intimacy kits and related contraceptive products under the HAVN brand. Based on the available evidence, it appears to operate as a commercial-stage product company in the sexual wellness and intimacy care segment, not as a traditional biotech or pharmaceutical developer. No evidence was found of a therapeutic R&D pipeline, clinical-stage assets, or target-based drug programs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on SafeGuard Ventures.